Microneedle Array‐Based Platforms for Future Theranostic Applications
Theranostics involves finding the biomarkers of a disease, fighting them through site specific drug delivery and following them for prognosis of the disease. Microneedle array technology has been used for drug delivery and extended for continuous monitoring of analytes present in the skin compartmen...
Saved in:
Published in | Chembiochem : a European journal of chemical biology Vol. 20; no. 17; pp. 2198 - 2202 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Wiley Subscription Services, Inc
02.09.2019
Wiley-VCH Verlag |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Theranostics involves finding the biomarkers of a disease, fighting them through site specific drug delivery and following them for prognosis of the disease. Microneedle array technology has been used for drug delivery and extended for continuous monitoring of analytes present in the skin compartment. We envisage the use of microneedle arrays for future theranostic applications. The potential of combining microneedle array‐based drug delivery and diagnostics as part of closed‐loop control system for the management of diseases and delivery of precision drugs in individual patients is reported in this paper.
The potential of combining microneedle array‐based drug delivery and diagnostics offers a minimally invasive route towards developing wearable closed‐loop control systems. Such systems can be used to manage a plethora of diseases that require continuous/frequent monitoring for subsequent delivery of precision drugs in individual patients. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 1439-4227 1439-7633 |
DOI: | 10.1002/cbic.201900112 |